Ontology highlight
ABSTRACT:
SUBMITTER: Davidson M
PROVIDER: S-EPMC5135398 | biostudies-literature | 2016
REPOSITORIES: biostudies-literature
Davidson Michael M Starling Naureen N
OncoTargets and therapy 20161125
The addition of trastuzumab to the treatment of a subset of patients with advanced gastric and gastroesophageal junction cancers showing HER2 positivity has been shown to confer clinical benefit; however, questions remain over the optimal methods for defining and selecting such patients. This review provides an overview of current standards for assessing HER2 positivity, the evolving treatment landscape for HER2-positive gastric and esophageal cancers and the challenges and potential future dire ...[more]